• 1
    Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 12211231.
  • 2
    Chavin KD, Yang S, Lin HZ et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 1999; 274: 56925700.
  • 3
    D'Alessandro AM, Kalayoglu M, Sollinger HW et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991; 51: 157163.
  • 4
    Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. The mechanism of injury in a steatotic liver graft during cold preservation. Transplantation 1999; 67: 195200.
  • 5
    Marsman WA, Wiesner RH, Rodriguez L et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996; 62: 12461251.
  • 6
    Seifalian AM, Piasecki C, Agarwal A, Davidson BR. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 1999; 68: 780784.
  • 7
    Taneja C, Prescott L, Koneru B. Critical preservation injury in rat fatty liver is to hepatocytes, not sinusoidal lining cells. Transplantation 1998; 65: 167172.
  • 8
    Hirsch J. The search for new ways to treat obesity. Proc Natl Acad Sci USA 2002; 99: 90969097.
  • 9
    Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 2001; 291: 26132616.
  • 10
    Matsusue K, Haluzik M, Lambert G et al. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 2003; 111: 737747.
  • 11
    Loftus TM, Jaworsky DE, Frehywot GL et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000; 288: 23792381.
  • 12
    Makimura H, Mizuno TM, Yang XJ et al. Cerulenin mimics effects of leptin on metabolic rate, food intake, and body weight independent of the melanocortin system, but unlike leptin, cerulenin fails to block neuroendocrine effects of fasting. Diabetes 2001; 50: 733739.
  • 13
    Mobbs CV, Makimura H. Block the FAS, lose the fat. Nat Med 2002; 8: 335336.
  • 14
    Army Medical Museum (US). LunaLC (ed). Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology, 3rd edn. New York : McGraw-Hill Co., 1968.
  • 15
    Preece A. A Manual for Histologic Technicians, 3rd edn. Boston : Carolina Press, 1985.
  • 16
    Cheng G, Polito CC, Haines JK et al. Decrease of intracellular ATP content downregulated UCP2 expression in mouse hepatocytes. Biochem Biophys Res Commun 2003; 308: 573580.
  • 17
    Larrouy D, Laharrague P, Carrera G et al. Kupffer cells are a dominant site of uncoupling protein 2 expression in rat liver. Biochem Biophys Res Commun 1997; 235: 760764.
  • 18
    Birsner J, Wan C, Cheng G et al. Steatotic liver transplantation in the mouse: a model of primary nonfunction. J Surg Res 2004; 120: 97101.
  • 19
    Nomura S, Horiuchi T, Omura S, Hata T. The action mechanism of cerulenin. J Biochem 1972; 71: 783796.
  • 20
    Zou Z, DiRusso CC, Ctrnacta V, Black PN. Fatty acid transport in Saccharomyces cerevisiae. Directed mutagenesis of FAT1 distinguishes the biochemical activities associated with Fat1p. J Biol Chem 2002; 277: 3106231071.